Skip to main content
. 2012 Mar 31;14(3):389–399. doi: 10.1208/s12248-012-9348-3

Fig. 6.

Fig. 6

Zr-89 trastuzumab uptake in various liver and bone lesions in three metastatic breast cancer patients as described in Dijkers et al. (71). The injected dose was 10 mg of Zr89-trastuzumab, 38 MBq (1 mCi) of Zr-89. Note the presence of multiple small bony and soft tissue lesions in these PET images illustrating the effective spatial resolution [from Fig. 3 in Dijkers et al. (71)]